NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	breast cancer
Date of first enrollment	01/09/2005
Target sample size
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : R340 (capecitabine) INN of investigational material : Therapeutic category code : 422 Antimetabolic agents Dosage and Administration for Investigational material : oral

Outcome(s)

Primary Outcome	objective response rate, time to response, duration of response, time to disease progression, overall survival, response rate stratified by previous treatment, safety profile
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	>= 20age old
Age maximum	<= 74age old
Gender	Female
Include criteria	1. Females 2. 20 and over Age and below 75 3. performance status 0-2, 4. Patients with a history of at least one regimen of chemotherapy including taxene (paclitaxel or docetaxel) (including (neo-) adjuvant therapy)
Exclude criteria